Patent · US Expired

Human-Th1-specific protein, gene encoding the protein, transformants, recombinant vectors, and antibodies related to the gene

US5962319A · kind A · utility

12Cited by
0References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 5, 1997
Grant dateOct 5, 1999
Priority date
Expiry dateJun 5, 2017

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/47
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

An element for specifying the condition and type of immune-related diseases on the basis of the knowledge about the polarization of distribution of Th1/Th2 subsets of helper T cells. The element for specifying or correcting the polarization of the Th1/Th2 subsets is implemented by use of a recombinant vector, a transformant, a human-Th1-specific protein, and an antibody which uses the human-Th1-specific protein as an antigen. A human-Th1-specific gene is prepared and specified by a subtraction technique and is incorporated into the recombinant vector. The transformant is formed by transforming the recombinant vector. The Th1-specific protein is encoded by the gene derived from the transformant.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.